[XENE] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
06-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 40.50%
YoY- -6.11%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 3,737 5,150 3,329 6,000 16 376 3,227 2.47%
PBT -25,080 -12,337 -11,412 -8,558 -8,065 -6,004 -3,937 36.11%
Tax 484 -14 -36 357 14 542 1,334 -15.53%
NP -25,564 -12,323 -11,376 -8,558 -8,065 -6,004 -3,937 36.54%
Tax Rate - - - - - - - -
Total Cost 29,301 17,473 14,705 14,558 8,081 6,380 7,164 26.43%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -684.08 -239.28 -341.72 -142.63 -50,406.25 -1,596.81 -122.00 33.25%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.62 -0.35 -0.34 -0.34 -0.45 -0.33 -0.27 14.84%
EPS Diluted -0.62 -0.33 -0.34 -0.33 -0.45 -0.33 -0.27 14.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.